JP2007532636A5 - - Google Patents

Download PDF

Info

Publication number
JP2007532636A5
JP2007532636A5 JP2007508299A JP2007508299A JP2007532636A5 JP 2007532636 A5 JP2007532636 A5 JP 2007532636A5 JP 2007508299 A JP2007508299 A JP 2007508299A JP 2007508299 A JP2007508299 A JP 2007508299A JP 2007532636 A5 JP2007532636 A5 JP 2007532636A5
Authority
JP
Japan
Prior art keywords
acid
depression
pharmaceutically acceptable
alkyl
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007508299A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007532636A (ja
Filing date
Publication date
Priority claimed from SE0400968A external-priority patent/SE0400968D0/xx
Application filed filed Critical
Publication of JP2007532636A publication Critical patent/JP2007532636A/ja
Publication of JP2007532636A5 publication Critical patent/JP2007532636A5/ja
Pending legal-status Critical Current

Links

JP2007508299A 2004-04-14 2005-04-06 Nk1アンタゴニスト及びセロトニン再取り込み阻害剤としての2−(アリールアルコキシ)−1−フェニルエチルアミン誘導体 Pending JP2007532636A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0400968A SE0400968D0 (sv) 2004-04-14 2004-04-14 Aryl glycine ether derivatives and their use
PCT/SE2005/000499 WO2005100324A1 (en) 2004-04-14 2005-04-06 2- ( arylalkoxy ) -1- phenylethylamine derivatives as nk1 antagonist and serotonin reuptake inhibitors

Publications (2)

Publication Number Publication Date
JP2007532636A JP2007532636A (ja) 2007-11-15
JP2007532636A5 true JP2007532636A5 (https=) 2008-05-22

Family

ID=32294310

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007508299A Pending JP2007532636A (ja) 2004-04-14 2005-04-06 Nk1アンタゴニスト及びセロトニン再取り込み阻害剤としての2−(アリールアルコキシ)−1−フェニルエチルアミン誘導体

Country Status (6)

Country Link
US (2) US7368448B2 (https=)
EP (1) EP1740552A1 (https=)
JP (1) JP2007532636A (https=)
CN (1) CN1956969A (https=)
SE (1) SE0400968D0 (https=)
WO (1) WO2005100324A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2460919A1 (fr) 1979-07-11 1981-01-30 Prod Synthese Ste Indle Amino-ethers oxydes, leur procede de preparation et leur application en therapeutique
US5389686A (en) 1989-02-20 1995-02-14 Jouveinal Sa Analgesic properties of fedotozine
US5245080A (en) 1989-02-20 1993-09-14 Jouveinal Sa (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-N-propylamine, process for preparing it and its therapeutical use
US5266599A (en) 1989-02-20 1993-11-30 Jouveinal S.A. Use of (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylamine to increase gastric discharge in a subject
US5362756A (en) 1989-02-20 1994-11-08 Riviere Pierre J M Use of fedotozine in the treatment of functional states of intestinal obstructions
GB9226581D0 (en) * 1992-12-21 1993-02-17 Merck Sharp & Dohme Therapeutic agents
EP1110958A1 (en) 1999-12-20 2001-06-27 Ucb, S.A. Alpha-arylethylpiperazine derivatives as neurokinin antagonists

Similar Documents

Publication Publication Date Title
JP7252908B2 (ja) S1p1活性を調節するための化合物およびその使用法
JP5833764B2 (ja) 縮合環を有するオキサゾリドン(oxazolidone)類の抗菌物質
US20070203120A1 (en) Sulfonyl Substituted 1H-Indoles as Ligands for the 5-Hydroxytryptamine Receptors
TW201920166A (zh) 二氫吡咯並吡啶衍生物
JP6054379B2 (ja) キナーゼをモジュレートするための組成物および方法
CN110049987A (zh) 制备(s)-n-(5-((r)-2-(2,5-二氟苯基)吡咯烷-1-基)-吡唑并[1,5-a]嘧啶-3-基)-3-羟基吡咯烷-1-甲酰胺及其盐的方法
TWI568733B (zh) 新穎的唏及1,1a,2,7b-四氫環丙烷[c]唏吡啶并吡化合物
BR122023004130B1 (pt) Compostos heteroaromáticos, composição farmacêutica e uso dos referidos compostos no tratamento de distúrbios mediados ou associados a dopamina d1
AU2015349866A1 (en) 4-oxo-3,4-dihydro-1,2,3-benzotriazines as modulators of GPR139
TW201105675A (en) Compounds and compositions for the treatment of parasitic diseases
CN1311681A (zh) 顽固性抑郁治疗的联合疗法
KR100767854B1 (ko) 피리딜옥시메틸 및 벤즈이속사졸 아자비시클릭 유도체
CN104725249A (zh) 苄胺类衍生物及其在药物上的应用
US20070299083A1 (en) 6-Methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts
JP2008543782A (ja) 5−ht1a受容体のピペラジン−ピペリジンアンタゴニストおよびアゴニスト
JP2007532636A5 (https=)
JP2007532638A5 (https=)
AU2006292256A1 (en) Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
JP2006502239A5 (https=)
US20080119481A1 (en) Crystalline forms of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline
CN103864762B (zh) 3,6-双(吡啶-4-基乙炔基)咔唑衍生物及其制备方法和应用
AU724646B2 (en) Method of treating common cold or allergic rhinitis
JP2006512363A5 (https=)
RU2004117091A (ru) Соль лимонной кислоты терапевтического соединения и фармацевтические композиции на ее основе
US20080221193A1 (en) 3-amino chromane derivatives